Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease. Biomed. Res. Ther. [Internet]. 2019 Jul. 4 [cited 2024 Nov. 15];6(7):3262-73. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/553